Article
Hedgehog pathway as a drug target: Smoothened inhibitors in development
1 Mar 2012
Abstract excerpt
Emerging laboratory and clinical investigations demonstrate that Hedgehog signaling (Hh) represents a novel therapeutic target in various human cancers. This conserved signaling pathway precisely regulates self-renewal and terminal differentiation in embryonic development, but is typically silenced in adult tissues, with reactivation usually only during tissue repair. Aberrant Hh pathway signaling has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
